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Each sample was tested by each of the laboratories using commercial and in house methods 5 adopted for routinely virologic monitoring of transplanted patients (Table 1 ). Nucleic acid 6 extraction was performed by the majority of the laboratories using automatic extraction with 7 commercial with sometimes in-house modifications; Real-time PCR amplification was carried out 8 by all the laboratories with commercially available kits, with only one exception. Quantitative 9 results were expressed as log 10 copies/ml for all three viruses tested. For positive samples detected 10 below the lowest limit of quantification, when a detected number of copies was not available, an 11 arbitrary value of half of the lowest limit of quantification was used. 12 
Results 23
The results obtained by the different GLaIT laboratories were analyzed to obtain a description of 24 intra-and inter-laboratory variability and a quantitative comparison with respect to the consensus 25 values reported by the different QCMD panels. 26
For each of the four panels tested (QCMD CMV plasma, CMV WB, EBV and BKV) no false 1 positive results were obtained by any of the GLaIT laboratories (specificity 100%). A sensitivity of 2 100% was achieved with the EBV and BKV evaluations. Concerning the CMV plasma panel, 3 sample #3 (2.24 log 10 copies/ml) was not detected by 1/15 (6.6%) centres and sample #4 (2.08 log 10 4 copies/ml) was not detected by 4/15 (26.6%) centres. For the CMV WB panel only sample #8 (2.58 5 log 10 copies/ml) was not detected by 4/13 (30.8%) centres. For the BKV/JCV panel, no cross 6 reactivity with the JCV virus was observed (6 samples) and all of the centres detected all the five 7 samples containing BKV. 8
The QCMD CMV plasma and WB panels contained duplicate samples to allow intra-laboratory 9 variability evaluation. The results indicated that the mean intra-laboratory % of the coefficient of 10 variation (CV) was 1.6 for CMV plasma and 3.0 for CMV WB. 11
In Table 2 , for each sample the mean, standard deviation (SD), CV (%), median and range of 12 log 10 copies/ml are reported. The mean SD for CMV plasma, CMV WB, EBV and BKV were 13 respectively 0.27, 0.49, 0.25 and 0.37. The mean % CV for CMV plasma, CMV WB, EBV and 14 BKV were respectively: 9.4%, 13.7%, 6.71% and 13.3%. The mean Delta log 10 for CMV plasma, 15 CMV WB, EBV and BKV were respectively: 0.93, 1.40, 0.97 and 1.29. It should be emphasized 16 that the variability was usually larger when considering samples with a virus concentration lower 17 than 3 log 10 copies/ml. were within ±0.5 log 10 difference. In the CMV plasma panel, the majority of the discordant results 1 (14/16, 87.5%) were observed in samples with a <3.0 log 10 DNA copies number ( Figure 1A) , while 2 in the CMV WB panel discordant results were observed for all sample concentrations ( Figure 1B) . 3
In the EBV panel ( Figure 1C ), 120/134 (89.6%) of the measurements were within a ±0.5 log 10 4 difference, with no evident differences among different sample concentrations. In the BKV panel 5 (Figure 1D ), a total of 56/75 (74.7%) determinations fell within ±0.5 log 10 difference; and for the 6 EBV panel, no differences among the different sample concentrations were detected. both CMV DNA quantification in plasma and WB. As for the former CMV study, no false positive 22 samples were obtained and a sensitivity of 100% was obtained in samples with a DNA load greater 23 than 3 log 10 copies/ml. Although in the past a variability of less than 1 log 10 was obtained only in 24 samples with a viral load greater than 3.7 log 10 copies/ml, the results reported here ranged from 0.93 25 to 1.40 log 10 variation for plasma and WB even when considering samples with concentrationsbelow 3.0 log 10 copies/ml. A greater variability was observed for CMV in WB with respect to 1 plasma; this is in line with the more complex matrix represented by blood, where nucleic acid 2 extraction is more laborious. At the same time, the CMV blood panel results, although more 3 variable, display a greater linearity. Overall, the % accuracy measured fell within ±0.5 log 10 and 4 ranged from 58.6% to 89.6%. This accuracy measured in a multicentre study is considered 5 acceptable and is higher than those observed in a similar study including fewer centres (n=4) [11] . 6
It should be underlined that in the present CMV quantification analysis, in contrast with previous 7 studies, all of the laboratories, with only one exception, used a commercial real-time PCR method 8 and only three different real-time methods were used. These real-time methods were however 9 associated with a variety of different manual or automated commercial and in house modified 10 protocols for nucleic acid extraction. It is reasonable to suppose that much of the variability 11 observed among the different quantifications was associated with the extraction procedures, rather 12 than the PCR amplification. This was also the case for EBV and BKV DNA determinations, where 13 as for CMV DNA, no false positive results were obtained for any samples. In the present study, the 14 best results (lower variability) were obtained with the EBV DNA panel. However, no direct 15 comparison can be made with the previous EBV study [10] 
